Showing 1 - 9 results of 9 for search 'William G Kerr', query time: 0.04s Refine Results
  1. 1
    SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn’s Disease and Peripheral T Cell Reduction

    SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn’s Disease and Peripheral T Cell Reduction by Sandra Fernandes, Neetu Srivastava, Raki Sudan, Frank A. Middleton, Frank A. Middleton, Frank A. Middleton, Amandeep K. Shergill, James C. Ryan, James C. Ryan, William G. Kerr, William G. Kerr, William G. Kerr

    Published 2018-05-01
    Get full text
    Article
  2. 2
    Targeting SHIP1 and SHIP2 in Cancer

    Targeting SHIP1 and SHIP2 in Cancer by Chiara Pedicone, Shea T. Meyer, John D. Chisholm, William G. Kerr

    Published 2021-02-01
    Get full text
    Article
  3. 3
    LRBA Deficiency Can Lead to Lethal Colitis That Is Diminished by SHIP1 Agonism

    LRBA Deficiency Can Lead to Lethal Colitis That Is Diminished by SHIP1 Agonism by Raki Sudan, Sandra Fernandes, Neetu Srivastava, Chiara Pedicone, Shea T. Meyer, John D. Chisholm, Robert W. Engelman, Robert W. Engelman, Robert W. Engelman, William G. Kerr, William G. Kerr

    Published 2022-05-01
    Get full text
    Article
  4. 4
    <i>N1</i>-Benzyl Tryptamine Pan-SHIP1/2 Inhibitors: Synthesis and Preliminary Biological Evaluation as Anti-Tumor Agents

    <i>N1</i>-Benzyl Tryptamine Pan-SHIP1/2 Inhibitors: Synthesis and Preliminary Biological Evaluation as Anti-Tumor Agents by Sandra Fernandes, Shea T. Meyer, Jigisha P. Shah, Arijit A. Adhikari, William G. Kerr, John D. Chisholm

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Structure–Activity Studies on Bis-Sulfonamide SHIP1 Activators

    Structure–Activity Studies on Bis-Sulfonamide SHIP1 Activators by Shea T. Meyer, Sandra Fernandes, Robert E. Anderson, Angela Pacherille, Bonnie Toms, William G. Kerr, John D. Chisholm

    Published 2023-12-01
    Get full text
    Article
  6. 6
    SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation

    SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation by Sandra Fernandes, Robert Brooks, Matthew Gumbleton, Mi-Young Park, Christopher M. Russo, Kyle T. Howard, John D. Chisholm, William G. Kerr

    Published 2015-03-01
    Get full text
    Article
  7. 7
    Selective deletion of SHIP-1 in hematopoietic cells in mice leads to severe lung inflammation involving ILC2 cells

    Selective deletion of SHIP-1 in hematopoietic cells in mice leads to severe lung inflammation involving ILC2 cells by Xujun Ye, Fengrui Zhang, Li Zhou, Yadong Wei, Li Zhang, Lihui Wang, Haiying Tang, Zi Chen, William G. Kerr, Tao Zheng, Zhou Zhu

    Published 2021-04-01
    Get full text
    Article
  8. 8
    Obesity control by SHIP inhibition requires pan-paralog inhibition and an intact eosinophil compartment

    Obesity control by SHIP inhibition requires pan-paralog inhibition and an intact eosinophil compartment by Sandra Fernandes, Neetu Srivastava, Chiara Pedicone, Raki Sudan, Elizabeth A. Luke, Otto M. Dungan, Angela Pacherille, Shea T. Meyer, Shawn Dormann, Stéphane Schurmans, Benedict J. Chambers, John D. Chisholm, William G. Kerr

    Published 2023-02-01
    Get full text
    Article
  9. 9
    Analysis of SHIP1 expression and activity in Crohn's disease patients.

    Analysis of SHIP1 expression and activity in Crohn's disease patients. by Rajesh Somasundaram, Sandra Fernandes, Jasper J Deuring, Colin de Haar, Ernst J Kuipers, Lauran Vogelaar, Frank A Middleton, C Janneke van der Woude, Maikel P Peppelenbosch, William G Kerr, Gwenny M Fuhler

    Published 2017-01-01
    Get full text
    Article

Search Tools: